Publications

Vivanco S. Protecting the movie industry from lead generated by pyrotechnic effects. Presentation to AMEC Technical Summit, 2014.

Wirbisky SE, Weber GJ, Lee JW, Cannon JR, Freeman JL. 2014. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity. Toxicol Lett 229(1):1–8; doi: 10.1016/j.toxlet.2014.05.016.

Movva N, Babik I, Galloway JC, Lobo MA. Use of an innovative rehabilitation device for infants to improve upper extremity functionality. Poster presentation at the Undergraduate Research and Service Celebratory Symposium, Newark, DE, August 2014.

Klaren WD, Robertson LW. PCB126-mediated disruption of hepatic metal homeostasis in mice coincides with increased metallothionein expression and appears to be independent of the canonical AhR pathway. Best Poster Award, University of Iowa Research Week, 2014.

Panko JM. Green chemistry: A critical element of sustainable development and product stewardship. Presentation at The American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, June 2014.

Kreider ML, Cyrs WD, Tosiano MA, Panko JM. Method development for nanomaterials exposure assessment in mixed dust environments. Presentation at  American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, May 2014.

Cyrs WD, Tosiano MA, Panko JM, Kreider ML. Use of a novel method to assess exposure to nanoscale carbon black and amorphous silica at two tire manufacturing facilities. Presentation at The American Industrial Hygiene Conference & Exposition (AIHce), San Antonio, TX, June 2014.

Wheeler MW, Dunson DB, Pandalai SP, Baker BA, Herring AH. 2014. Mechanistic hierarchical Gaussian processes. J Amer Stat Assoc 109(507):894-904; doi: 10.1080/01621459.2014.899234. PMCID: PMC4273873.

Panko JM. Chemical selection tools analysis project and results. Presented at GlobalChem. Global Chemical Regulations Conference, Baltimore, MD, March 2014.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Pinto DS, Nicholson G, Harrington RA, Cyr PL, Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol 34(9):939–967; doi: 10.1002/jat.3039.

Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570.

Finley BL, Scott PK. 2014. Diacetyl and “popcorn lung” litigation: Assessing the evidence for general causation. ABA Environ Litigation Toxic Torts Newsletter 15(2):7–10.

Kerger BD, Thuett KA, Finley BL. 2014. Evaluation of four a-diketones for toll-like receptor-4 (TLR-4) activation in a human transfected cell line. Food Chem Toxicol 74(Dec):117–119; doi: 10.1016/j.fct.2014.09.010.

Reichert H, McMahon LF, Meddings J. Risk-adjusting hospital-acquired pressure ulcer rates from administrative data: How do hospitals perform by the risk-adjusted AHRQ Patient Safety Indicator 3 compared to a proposed measure using risk-standardization applied by the Centers for Medicare and Medicaid Services for other outcomes? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.

Reichert H, McMahon LF, Meddings J. Did hospital-acquired pressure ulcer rates decrease after implementation of non-payment as a comorbidity with the 2008 Hospital-Acquired Conditions Initiative? Presented at the Academy Health Annual Research Meeting, San Diego, CA, June 2014.